ArticleNanoscale advances2026
Levofloxacin-loaded surfactant nanocarriers: a computational study.
Article in Nanoscale advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We performed extensive all-atom molecular dynamics simulations to investigate the interaction dynamics and orientation of levofloxacin, a newer fluoroquinolone antibiotic, with anionic (SDS) and cationic (CTAB) micelles. The maximum drug/micelle ratio (loading capacity and entrapment efficiency) was estimated for anionic and cationic micelles. High encapsulation efficiencies were observed for SDS (average: ∼80%). In contrast, for CTAB micelles, the efficiency was ∼8%, indicating that the binding of levofloxacin molecules to SDS micelles is significantly higher than that to CTAB micelles. Tilted orientations were observed for levofloxacin in SDS micelles (∼48-51°) and in CTAB micelles (∼40-42°), where the positively charged piperazine group is anchored to anionic headgroups. In contrast, the negatively charged carboxylic group is close to cationic headgroups. Calculating the relative binding energies, we found that levofloxacin binds more strongly to SDS than CTAB. Due to π-π interactions and hydrogen bonding, the formation of concerted columnar stacks of levofloxacin was also recorded for both anionic and cationic micelles.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.